A new Ontario-based study has found a significant rise in prescriptions for stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), particularly among adults and females.
Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of ...
Medical Device Network on MSN
FDA greenlights Lumos Labs’ digital ADHD therapeutic
Lumos Labs’ LumosityRx is positioned for use alongside other ADHD treatment modalities such as medication and therapy.
For the millions of Americans touched by Alzheimer’s disease, 2025 brought major advances in understanding of brain health ...
Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, ...
LumosityRx is a prescription therapeutic app that includes 13 cognitive training games targeting key brain processes connected to attention function.
CBT is an evidence-supported treatment for adult ADHD. Evolving trends in CBT have already improved adult ADHD treatment, and ...
In some parts of the world, record numbers of people are being diagnosed with attention deficit hyperactivity disorder (ADHD) ...
Prison officials are trying to reduce the risk of overdose by providing medications for opioid use disorder before release.
A new online tool is designed to help families and clinicians make informed treatment decisions. The most extensive ...
A University of Southampton study finds medication is the most effective ADHD treatment for children and adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results